. A cocktail of composite chromosome-specific DNA probes are used in combination with pan-centromeric probes to discriminate between reciprocal translocations and dicentrics (e.g., see Lucas et a/. 1992a; Straume and Lucas 1993) . Chromosome painting is generally performed using DNA probes specific for only a sub-set of the genome, e.g., chromosomes 1 , 2, and 4, which in combination results in the detection of 35% of all translocations.
Comparisons with results from conventional cytogenetic methods requires scaling-up the chromosome painting results to full genome equivalents. As described below, we have demonstrated that such scaling can be performed accurately by assuming that radiation results in a random distribution of chromosome breaks.
To visualize interchromosomal exchanges, the metaphase chromosomes are stained yellow with probes for the selected target chromosomes and red for the non-target chromosomes (e.g., see Fig. 1 in Lucas et ai. 1992a) . With the additional application of blue pan-centromeric probes, the discrimination between translocations and dicentrics is made possible. Thus, exchange aberrations are recognized as bi-color (part red and part yellow) chromosomes, and are scored as reciprocal translocations if the two derivative chromosomes each have one blue-stained centromere and as dicentrics if the derivative chromosomes have two centromeres and a bi-color acentric fragment.
As indicated above, full genomic translocation frequencies are accurately obtained after painting only a small fraction of the genome. This important finding was determined by comparing in the same individuals reciprocal translocation frequencies measured using FISH and G-banding (Lucas et al. 1992a ). The frequencies measured using FISH for chromosomes 1, 2 and 4 (Le., 22% of the genome) were converted to/full genome equivalents and then
Introduction
There is a need for reliable methods to assess past clastogenic exposures and to assess risk. This is particularly the case for a large number of individuals exposed to various levels of ionizing radiation as a result of nuclear accidents such as Chernobyl, atmospheric nuclear testing prior to the early 196O's, past human experimentation by US Government agencies, the atom bombs dropped on Hiroshima and Nagasaki, various medical radiological procedures, occupational exposures, and a variety of other exposures for which dosimetry information may be poor or absent.
The efforts in our laboratory have centered principally on the development and validation of a technology referred to as 'chromosome painting" for use in human exposure and risk assessment. This technology employs fluorescence in situ hybridization (FISH) with whole chromosome probes to rapidly and accurately detect chromosome abnormalities such as stable reciprocal translocations in human cells. The development of this technology began at LLNL during the early 1980's (Pinkel et al. 1986 ) and has now developed into the method of choice world-wide for the detection of chromosome translocations in humans (e.g., see Lucas et al. 1992a; Nakano et al. 1993; Bauchinger et al. 1993; Straume et al. 1995; National Research Council 1995) .
Methodology
The method employs lymphocytes obtained from a small blood sample taken from the individual to be evaluated. 
Human Studies
To date, we have evaluated four individuals previously exposed to penetrating whole-body radiation, either accidentally or during normal work situations. Each of these four cases were exposed to different kinds of radiation, patterns of exposure, and dose rates. All, however, had in common exceptionally good independent dosimetry against which our biodosimetry results could be compared.
The first case, a DOE radiation worker exposed occupationally during the 1950'~~ 1960'~~ and early 1970s was also evaluated biodosimetrically using four different assays, including translocations measured by chromosome painting (Straume et al. 1992 Sv for translocations measured using FISH.
Taken together, these case studies suggest that the frequency of reciprocal translocations in human lymphocytes provide an accurate measure of prior exposure to ionizing radiation in whole-body exposed individuals, regardless of the temporal pattern of the exposure or the kind of radiations involved.
Additional individuals with good independent dosimetry are of course being sought to continue these very important validation studies.
Chromosome translocation studies have also been performed on large numbers of individuals such as atom-bomb survivors and criticality accident victims. However, in those cases, the independent dosimetry is uncertain and cytogenetic analyses were not made soon after the radiation exposure. It is nevertheless informative that cytogenetic follow-up for those populations (which unfortunately began many years after the exposure occurred) has shown that the translocation frequencies measured in blood lymphocytes of exposed individuals do not change with time when the same individuals are re-sampled many years later. Individuals and groups from which temporal stability information h a s been obtained are shown in Fig. 1 . It is seen that prior to our 
Non-Human Primate Studies
Rhesus monkeys were exposed in 1965 to whole-body (fully penetrating) radiation in connection with NASA studies (Hardy 1991 
In Vitro Studies
The use a biomarker for quantitative evaluation of exposure and dose assessment requires good calibration curves. Such curves provide a relationship between biomarker frequency and dose, and must therefore be obtained for relevant exposure conditions. For radiation-induced chromosome aberrations, calibration curves are generally obtained using human lymphocytes exposed in vitro, which have been shown to be identical to those exposed in vivo (e.g., Brewen and Gengozian 1971). 
Blodosimetry for Leukemia Patients
A substantial amount of genetic damage appears in the blood cells of leukemia patients due to the well known phenomenon of genetic instability of cancer cells. This is of particular significance for biological dosimetry because the malignant lymphocytes can mask the genetic damage that may have been caused by radiation or other clastogens prior to the disease. We have developed a new approach that may be used to measure pre-cancer-induced chromosomal aberrations in patients with 8-cell leukemia by totally separating the unaffected T lymphocytes from the malignant B lymphocytes (Lucas et al. 1994) . Results suggest that pre-leukemia exposure to radiation may be biodosimetncally quantified from translocations frequencies in a certain subset of blood lymphocytes of leukemia patients as long as the blood sample is obtained prior to radio-or chemo-therapy (Lucas et al., 1994) . This method fills an important need in the establishment of prior exposures that may have contributed to the induction of leukemia or lymphoma.
Other Considerations
Variables such as spontaneous translocation frequencies in unexposed individuals and non-uniform body dose in exposed individuals are also being addressed. We have measured about two dozen unexposed controls of varying ages, from -20 to more than 60 years of age. The translocation frequencies range from -2 to 10 per 1000 cells (Bender et 
Conclusion
When the human case studies are considered together with the results for non-human primates, the overall biodosimetry data are now beginning to provide a strong basis for the use of chromosome translocations detected by FISH in retrospective dosimetry and risk assessment, no matter how long ago the exposure occurred or whether the exposure was received acutely or chronically.
